Diversity and versatility of p38 kinase signalling in health and disease

B Canovas, AR Nebreda - Nature reviews Molecular cell biology, 2021 - nature.com
The ability of cells to deal with different types of stressful situations in a precise and
coordinated manner is key for survival and involves various signalling networks. Over the …

Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity

S Lee, J Rauch, W Kolch - International journal of molecular sciences, 2020 - mdpi.com
Mitogen-activated protein kinase (MAPK) pathways represent ubiquitous signal transduction
pathways that regulate all aspects of life and are frequently altered in disease. Here, we …

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

A Lin, CJ Giuliano, A Palladino, KM John… - Science translational …, 2019 - science.org
Ninety-seven percent of drug-indication pairs that are tested in clinical trials in oncology
never advance to receive US Food and Drug Administration approval. While lack of efficacy …

mTOR‐mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATP

Y Hu, W Mai, L Chen, K Cao, B Zhang, Z Zhang, Y Liu… - Glia, 2020 - Wiley Online Library
Microglia constantly survey the brain microenvironment and rapidly adopt different
phenotypes in response to environmental stimuli. Such dynamic functions require a unique …

Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma

MY Li, LN Fan, DH Han, Z Yu, J Ma… - The Journal of …, 2020 - Am Soc Clin Investig
Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive cancers and is
highly resistant to current treatments. ESCC harbors a subpopulation of cells exhibiting …

Emerging role of microRNAs in mTOR signaling

Y Zhang, B Huang, HY Wang, A Chang… - Cellular and Molecular …, 2017 - Springer
Mechanistic target of rapamycin (mTOR) is a conserved serine/threonine kinase that plays a
critical role in the control of cellular growth and metabolism. Hyperactivation of mTOR …

cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mTORC1 axis

G Li, FF She, CY Liao, ZW Wang, YT Wang… - Cell Death & …, 2024 - nature.com
Resistance to gemcitabine in pancreatic ductal adenocarcinoma (PDAC) leads to ineffective
chemotherapy and, consequently, delayed treatment, thereby contributing to poor prognosis …

The p38 MAPK signaling activation in colorectal cancer upon therapeutic treatments

A Pranteda, V Piastra, L Stramucci… - International Journal of …, 2020 - mdpi.com
Pharmacological treatment of colorectal carcinoma currently proceeds through the
administration of a combination of different chemotherapeutic agents. In the case of rectal …

Amino acids-Rab1A-mTORC1 signaling controls whole-body glucose homeostasis

X Zhang, X Wang, Z Yuan, SJ Radford, C Liu, SK Libutti… - Cell Reports, 2021 - cell.com
Rab1A is a small GTPase known for its role in vesicular trafficking. Recent evidence
indicates that Rab1A is essential for amino acids (aas) sensing and signaling to regulate …

The ion transporter NKCC1 links cell volume to cell mass regulation by suppressing mTORC1

WL Demian, A Persaud, C Jiang, É Coyaud, S Liu… - Cell reports, 2019 - cell.com
Summary mTORC1 regulates cellular growth and is activated by growth factors and by
essential amino acids such as Leu. Leu enters cells via the Leu transporter LAT1-4F2hc …